1st Quarter - Report

MCDERMOTT WILL & SCHULTE LLP for ISIS PHARMACEUTICALS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.

LobbyistCovered position, as disclosed
DAVID DUANE RANSOM Member)
STEPHEN M RYAN Deputy Counsel, President's Commission on
KAREN SEALANDER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Pharmacy PHA

Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.

LobbyistCovered position, as disclosed
DAVID DUANE RANSOM Member).
STEPHEN M RYAN Organized Crime.
KAREN SEALANDER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 23 (112th), H.R. 1249 (112th)

Medical/Disease Research/Clinical Labs MED

Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.

LobbyistCovered position, as disclosed
DAVID DUANE RANSOM Member).
STEPHEN M RYAN Organized Crime.
KAREN SEALANDER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.